Literature DB >> 16602702

Molecular profiling of hepatocellular carcinoma in mice with a chronic deficiency of hepatic s-adenosylmethionine: relevance in human liver diseases.

Enrique Santamaría1, Javier Muñoz, Joaquín Fernandez-Irigoyen, Laura Sesma, María I Mora, Carmen Berasain, Shelly C Lu, José M Mato, Jesús Prieto, Matías A Avila, Fernando J Corrales.   

Abstract

S-adenosylmethionine arises as a central molecule in the preservation of liver homeostasis as a chronic hepatic deficiency results in spontaneous development of steatohepatitis and hepatocellular carcinoma. In the present work, we have attempted a comprehensive analysis of proteins associated with hepatocarcinogenesis in MAT1A knock out mice using a combination of two-dimensional electrophoresis and mass spectrometry, to then apply the resulting information to identify hallmarks of human HCC. Our results suggest the existence of individual-specific factors that might condition the development of preneoplastic lesions. Proteomic analysis allowed the identification of 151 differential proteins in MAT1A-/- mice tumors. Among all differential proteins, 27 changed in at least 50% of the analyzed tumors, and some of these alterations were already detected months before the development of HCC in the KO liver. The expression level of genes coding for 13 of these proteins was markedly decreased in human HCC. Interestingly, seven of these genes were also found to be down-regulated in a pretumoral condition such as cirrhosis, while depletion of only one marker was assessed in less severe liver disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16602702     DOI: 10.1021/pr050429v

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.

Authors:  Paul C Schröder; Víctor Segura; José Ignacio Riezu; Bruno Sangro; José M Mato; Jesús Prieto; Enrique Santamaría; Fernando J Corrales
Journal:  Funct Integr Genomics       Date:  2011-05-12       Impact factor: 3.410

2.  Non-alcoholic fatty liver disease proteomics.

Authors:  Eva Rodríguez-Suárez; Antonio M Duce; Juan Caballería; Félix Martínez Arrieta; Estefanía Fernández; Carolina Gómara; Nere Alkorta; Usue Ariz; M Luz Martínez-Chantar; Shelly C Lu; Felix Elortza; José M Mato
Journal:  Proteomics Clin Appl       Date:  2010-02-03       Impact factor: 3.494

3.  Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.

Authors:  Irina A Kirpich; Leila N Gobejishvili; Marjorie Bon Homme; Sabine Waigel; Matt Cave; Gavin Arteel; Shirish S Barve; Craig J McClain; Ion V Deaciuc
Journal:  J Nutr Biochem       Date:  2010-03-20       Impact factor: 6.048

4.  A possible predictive marker of progression for hepatocellular carcinoma.

Authors:  Michele DI Stasio; Maria Grazia Volpe; Giovanni Colonna; Melissa Nazzaro; Miriam Polimeno; Stefania Scala; Giuseppe Castello; Susan Costantini
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

Review 5.  Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma.

Authors:  William Matthew Puszyk; Thu Le Trinh; Sarah J Chapple; Chen Liu
Journal:  Lab Invest       Date:  2013-08-05       Impact factor: 5.662

6.  Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylation.

Authors:  Donghong Zhang; Jinli Lou; Xu Zhang; Lin Zhang; Fei Wang; Danfei Xu; Na Niu; Yidong Wang; Yue Wu; Wei Cui
Journal:  Oncotarget       Date:  2017-02-28

Review 7.  Alcohol and hepatocellular carcinoma.

Authors:  Hiroshi Matsushita; Akinobu Takaki
Journal:  BMJ Open Gastroenterol       Date:  2019-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.